Initiator Pharma A/sOMXSTO: INIT

Initiator Pharma Gets UK CTA Approval For Phase 2a Study

· Issued by Initiator Pharma A/s

Initiator Pharma A/S OMXSTO:INIT:

  • RECEIVES UK CTA APPROVAL TO INITIATE PHASE 2A STUDY IN VULVODYNIA

  • FIRST PATIENTS EXPECTED TO BE ENROLLED IN Q4 2025